We are live on ! Find out more
LFCM

Long Focus Capital Management Portfolio holdings

AUM $3.8B
1-Year Est. Return 7.31%
This Fund
S&P 500
This Quarter Est. Return
+4.34%
1 Year Est. Return
+7.31%
3 Year Est. Return
+112%
5 Year Est. Return
10 Year Est. Return
AUM
$3.8B
AUM Growth
+$775M
Cap. Flow
+$794M
Cap. Flow %
20.9%
Top 10 Hldgs %
49.83%
Holding
103
New
9
Increased
31
Reduced
21
Closed
11

Top Buys

Rank Stock Value
1
RKT icon
Rocket Companies
RKT
+$50.4M
2
AMZN icon
Amazon
AMZN
+$48.8M
3
GLNG icon
Golar LNG
GLNG
+$34M
4
MOH icon
Molina Healthcare
MOH
+$32.5M
5
PYPL icon
PayPal
PYPL
+$31.1M

Top Sells

Rank Stock Value
1
INSM icon
Insmed
INSM
+$38.9M
2
AKRO
Akero Therapeutics
AKRO
+$34.2M
3
HLF icon
Herbalife
HLF
+$12.7M
4
VSAT icon
Viasat
VSAT
+$10.4M
5
TE
T1 Energy
TE
+$10.1M

Sector Composition

Rank Sector Weight
1 Healthcare 13.82%
2 Financials 8.15%
3 Communication Services 6.98%
4 Industrials 6.58%
5 Consumer Discretionary 6.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PCT icon
101
PureCycle Technologies
PCT
$1.45B
-589,413
Closed -$7.75M
NESR
102
National Energy Services Reunited Corp
NESR
$2.96B
-350,000
Closed -$3.59M

Similar funds

Long Focus Capital Management's Q4 2025 Portfolio in Review

As of Q4 2025, Long Focus Capital Management held 103 positions worth $3.8B, up 26% from $3.03B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Long Focus Capital Management deployed $794M of net new capital in Q4 2025, opening 9 new positions and adding to 31 existing holdings. Its largest new stake was Rocket Companies: 2,820,000 shares worth $54.6M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 18% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was Insmed, an estimated $38.9M trimmed.

  • Long Focus Capital Management's largest Q4 2025 buy was Rocket Companies: 2,820,000 shares worth $54.6M.
  • Long Focus Capital Management added most to Golar LNG in Q4 2025, an estimated $34M increase.
  • Long Focus Capital Management's biggest Q4 2025 reduction was Insmed, cutting an estimated $38.9M.
  • Long Focus Capital Management fully exited Akero Therapeutics in Q4 2025, selling an estimated $34.2M.
  • Long Focus Capital Management's ten largest holdings make up 50% of its $3.8B portfolio in Q4 2025.
  • Long Focus Capital Management opened 9 new positions and closed 11 in Q4 2025.
  • Long Focus Capital Management's portfolio value rose 26% quarter-over-quarter to $3.8B.

Based on Long Focus Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.